NEUROPACE, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
NEUROPACE, INC. (NPCE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.06 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.84M shares, a 12.17% decline year-over-year.
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 4.37M shares, a 8.36% decline year-over-year.
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 4.77M shares, a 30.74% decline year-over-year.
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 6.88M shares, a 21.97% increase year-over-year.
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.84M shares, a 1.99% decline from fiscal 2024.
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.92M shares, a 23.66% decline from fiscal 2023.
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.13M shares, a 6.23% decline from fiscal 2022.
- NEUROPACE, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.47M shares, a 39.45% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.06M shares 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 3.84M shares 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 3.84M shares 10-K · filed 2026-03-03 | |||
| 2025-09-30 | 4.10M shares 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 4.32M shares 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | 4.37M shares 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 3.92M shares 10-K · filed 2026-03-03 | |||
| 2024-09-30 | 4.17M shares 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | 4.32M shares 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | 4.77M shares 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | 5.13M shares 10-K · filed 2025-03-04 | |||
| 2023-09-30 | 5.66M shares 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 6.61M shares 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | 6.88M shares 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 5.47M shares 10-K · filed 2024-03-05 | |||
| 2022-09-30 | 5.57M shares 10-Q · filed 2023-11-06 | |||
| 2022-06-30 | 5.68M shares 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | 5.64M shares 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | 3.92M shares 10-K · filed 2023-03-02 | |||
| 2021-09-30 | 3.89M shares 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | 3.88M shares 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | 19.97M shares 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 19.83M shares 10-K · filed 2022-03-10 | |||
| 2020-09-30 | 17.13M shares 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | 810.50K shares 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | 811.49K shares 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |